VUMC News and Communications

February 13, 2012

Flexner Lecture to discuss medical school curriculum reform

By VUMC News and Communications
February 13, 2012

Take advantage of these opportunities to support Children’s Hospital

By VUMC News and Communications
February 10, 2012

Opinion: Scientific research is essential to state’s economic health

In this Tennessean opinion piece, Vice Chancellor for Health Affairs Jeff Balser discusses the impact scientific research has in Tennessee and the critical importance of continued federal investment in this research.

By VUMC News and Communications
February 10, 2012

Dr. Howard Kirshner on stroke prevention

By VUMC News and Communications
February 3, 2012

Help put childhood cancer on ice at Predators game March 10

By VUMC News and Communications
February 2, 2012

Dr. Michael Neuss: “How much progress has been made in the fight against cancer?”

By VUMC News and Communications
February 1, 2012

Treatment window for genetic disorder

Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.
By VUMC News and Communications
February 1, 2012

Drugs reverse lung cancer cell changes

Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.
By VUMC News and Communications
January 26, 2012

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.
By VUMC News and Communications
January 26, 2012

“My Health Chat” takes on autism, other developmental disabilities

By VUMC News and Communications
January 26, 2012

Tenth annual Dance Marathon set for Feb. 17-18

By VUMC News and Communications
January 25, 2012

Protein repairs esophageal DNA damage

A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.
By VUMC News and Communications